DK1280809T3 - Antitumorecteinascidinderivater - Google Patents

Antitumorecteinascidinderivater

Info

Publication number
DK1280809T3
DK1280809T3 DK01919669T DK01919669T DK1280809T3 DK 1280809 T3 DK1280809 T3 DK 1280809T3 DK 01919669 T DK01919669 T DK 01919669T DK 01919669 T DK01919669 T DK 01919669T DK 1280809 T3 DK1280809 T3 DK 1280809T3
Authority
DK
Denmark
Prior art keywords
antitumorecteinascidin
derivatives
antitumorecteinascidin derivatives
Prior art date
Application number
DK01919669T
Other languages
English (en)
Inventor
Maria Flores
Andres Francesch
Pilar Gallego
Jose Luis Chicharro
Maria Zarzuelo
Carolina Fernandez
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009043A external-priority patent/GB0009043D0/en
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Priority claimed from GB0022644A external-priority patent/GB0022644D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK1280809T3 publication Critical patent/DK1280809T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK01919669T 2000-04-12 2001-04-12 Antitumorecteinascidinderivater DK1280809T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0009043A GB0009043D0 (en) 2000-04-12 2000-04-12 New autitumoural derivatives of ET-743
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
GB0022644A GB0022644D0 (en) 2000-09-14 2000-09-14 Antitumoral derivatives of ET-743

Publications (1)

Publication Number Publication Date
DK1280809T3 true DK1280809T3 (da) 2005-11-07

Family

ID=26244092

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01919669T DK1280809T3 (da) 2000-04-12 2001-04-12 Antitumorecteinascidinderivater

Country Status (27)

Country Link
US (1) US7202361B2 (da)
EP (1) EP1280809B1 (da)
JP (1) JP5219323B2 (da)
KR (1) KR100886496B1 (da)
CN (1) CN1436191B (da)
AR (1) AR032879A1 (da)
AT (1) ATE299146T1 (da)
AU (1) AU784249C (da)
BG (1) BG65987B1 (da)
BR (1) BRPI0110024B8 (da)
CA (1) CA2406080C (da)
CZ (1) CZ304749B6 (da)
DE (1) DE60111845T2 (da)
DK (1) DK1280809T3 (da)
EA (1) EA006206B1 (da)
ES (1) ES2244598T3 (da)
HK (1) HK1049005B (da)
HU (1) HU230918B1 (da)
IL (1) IL152094A (da)
MX (1) MXPA02010088A (da)
NO (1) NO329125B1 (da)
NZ (1) NZ521550A (da)
PL (1) PL210703B1 (da)
PT (1) PT1280809E (da)
SI (1) SI1280809T1 (da)
SK (1) SK288017B6 (da)
WO (1) WO2001077115A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139607A0 (en) * 1998-05-11 2002-02-10 Pharma Mar Sa Metabolites of ecteinascidin 743
MY164077A (en) 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
GB0117402D0 (en) 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
BR0213424A (pt) * 2001-10-19 2004-12-14 Pharma Mar Sa Uso aperfeiçoado de composto antitumoral na terapia contra câncer
JP4208469B2 (ja) * 2002-01-29 2009-01-14 独立行政法人科学技術振興機構 エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US7622458B2 (en) 2003-11-13 2009-11-24 Pharma Mar, S.A.U. Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatment
JP2008514688A (ja) * 2004-09-29 2008-05-08 ファルマ・マル・エス・アー， ソシエダッド・ユニペルソナル 抗炎症剤としてのエクテイナシジン化合物
WO2006046079A1 (en) 2004-10-29 2006-05-04 Pharma Mar S.A., Sociedad Unipersonal Formulations comprising ecteinascidin and a disaccharide
WO2006083417A2 (en) * 2004-12-20 2006-08-10 The Trustees Of Columbia University In The City Of New York Processes of making sesquiterpenoid tashironin, its analogs and their uses
WO2006079112A2 (en) * 2005-01-18 2006-07-27 The Trustees Of Columbia University In The City Of New York Enantioselective synthesis of merrilactone a and its analogs
GB0522082D0 (en) 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
WO2007087220A2 (en) * 2006-01-25 2007-08-02 The Trustees Of Columbia University In The City Of New York The total synthesis of ecteinascidin 743 and derivatives thereof
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
CN107033164A (zh) 2010-05-25 2017-08-11 法马马有限公司 制备海鞘素化合物的合成方法
DK2786753T3 (da) 2010-11-12 2019-04-15 Pharma Mar Sa Kombinationsterapi med et antitumorantibiotikum
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112679513B (zh) * 2019-10-18 2023-08-25 南通诺泰生物医药技术有限公司 一种制备曲贝替定的关键中间体的方法
CN114940682A (zh) * 2022-05-18 2022-08-26 博瑞制药(苏州)有限公司 芦比替定的晶型及其制备方法和用途
CN115677728A (zh) * 2022-11-02 2023-02-03 成都科岭源医药技术有限公司 一种海鞘素类化合物中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
JPS6084288A (ja) 1983-10-13 1985-05-13 Shionogi & Co Ltd シアノキノナミンアセテ−ト類およびその製造法
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
DE3774435D1 (de) 1986-06-09 1991-12-12 Univ Pennsylvania Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US5985876A (en) 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
IL139607A0 (en) * 1998-05-11 2002-02-10 Pharma Mar Sa Metabolites of ecteinascidin 743
US6124292A (en) 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743
MY130271A (en) 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
US6686470B2 (en) * 2000-01-19 2004-02-03 The Trustees Of Columbia University In The City Of New York Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.

Also Published As

Publication number Publication date
CN1436193A (zh) 2003-08-13
EP1280809A1 (en) 2003-02-05
CN1436191B (zh) 2011-09-14
HK1049005B (zh) 2006-01-27
SI1280809T1 (sl) 2005-12-31
IL152094A0 (en) 2003-05-29
AU4672901A (en) 2001-10-23
AU784249C (en) 2007-05-03
BG65987B1 (bg) 2010-08-31
CZ304749B6 (cs) 2014-09-24
ES2244598T3 (es) 2005-12-16
US7202361B2 (en) 2007-04-10
DE60111845D1 (de) 2005-08-11
CA2406080C (en) 2011-11-29
BRPI0110024B8 (pt) 2021-05-25
US20030216397A1 (en) 2003-11-20
SK288017B6 (sk) 2012-11-05
NZ521550A (en) 2004-10-29
JP5219323B2 (ja) 2013-06-26
BRPI0110024B1 (pt) 2019-07-16
EP1280809B1 (en) 2005-07-06
PL210703B1 (pl) 2012-02-29
NO20024906D0 (no) 2002-10-11
EA006206B1 (ru) 2005-10-27
BG107220A (en) 2003-05-30
HUP0300534A2 (hu) 2003-07-28
SK14352002A3 (sk) 2003-04-01
KR20030012864A (ko) 2003-02-12
MXPA02010088A (es) 2004-08-19
KR100886496B1 (ko) 2009-03-05
CA2406080A1 (en) 2001-10-18
WO2001077115A1 (en) 2001-10-18
IL152094A (en) 2011-10-31
AR032879A1 (es) 2003-12-03
JP2003530402A (ja) 2003-10-14
BR0110024A (pt) 2003-02-18
HU230918B1 (hu) 2019-03-28
PT1280809E (pt) 2005-11-30
NO329125B1 (no) 2010-08-30
AU784249B2 (en) 2006-02-23
CZ20023352A3 (cs) 2003-05-14
HUP0300534A3 (en) 2006-02-28
HK1049005A1 (en) 2003-04-25
EA200201083A1 (ru) 2003-04-24
DE60111845T2 (de) 2006-04-27
PL357574A1 (en) 2004-07-26
NO20024906L (no) 2002-11-27
ATE299146T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DE60140253D1 (de) Oreinheit
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
DK1571140T3 (da) Substituerede C-cyjklohexylmethylamin-derivater
AR028602A1 (es) Derivados de pirrol
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
NO20010790L (no) Styrtgodts-lastevogn
AR028282A1 (es) Derivados de aminofenil pirimidona
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
PT1351959E (pt) Novos derivados de pleuromutilina
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
NO20013985L (no) Orto-fenylfenolatkonsentrater
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
AT500246B8 (de) Chokerring
ATA11602000A (de) Sonnenstandsnachführungssystem
ATA12252000A (de) Regensinkkasten
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater
ATA11632001A (de) Fräsbrecherfahrzeug
ATA18812000A (de) Bodenplatte